LATS2 and non-small cell lung carcinoma: LUAD accounted for the majority of NSCLC and the high expression of LATS2 acted as a protective factor for OS in LUAD patients (log-rank p = 3.9e-9, HR = 0.47, 95%CI = 0.36–0.6.